ARROWHEAD PHARMACEUTICALS, INC. Marketable Securities (Current)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Marketable Securities (Current) of $0 as of 2022-09-30, per its 10-K filed 2022-11-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2022-11-28
- 2022-09-30: Marketable Securities, Current $0.00.
- 2022-06-30: Marketable Securities, Current $0.00.
- 2022-03-31: Marketable Securities, Current $122.58M.
- 2021-12-31: Marketable Securities, Current $126.01M.
| Period end | Marketable Securities, Current | Marketable Securities, Current as first filed |
|---|---|---|
| 2022-09-30 | $0.00 10-K · filed 2022-11-28 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $122.58M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $126.01M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $126.73M 10-K · filed 2022-11-28 | |
| 2021-06-30 | $126.41M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $125.79M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $86.01M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $85.02M 10-K · filed 2021-11-22 | $85.02M 10-K · filed 2020-11-23 |
| 2014-12-31 | $23.53M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $21.65M 10-Q · filed 2015-02-09 | |
| 2014-06-30 | $23.83M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $17.80M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $15.91M 10-Q · filed 2014-02-04 | |
| 2013-09-30 | $9.03M 10-K · filed 2014-11-25 | |
| 2013-06-30 | $4.06M 10-Q · filed 2013-08-07 | |
| 2012-12-31 | $56.01K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $106.50K 10-K · filed 2013-12-18 | |
| 2012-06-30 | $108.97K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $78.68K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $71.83K 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $634.59K 10-K · filed 2012-12-28 | |
| 2011-06-30 | $1.18M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |